Benzinga's Top Upgrades

Analysts at Argus Research upgraded

from Hold to Buy. The price target for Gannett is set to $20. Gannett shares closed at $16.09 on Wednesday. Roth Capital upgraded

from Neutral to Buy. The price target for Cogentix Medical has been raised from $1.85 to $3. Cogentix Medical shares closed at $1.52 on Wednesday. Analysts at B. Riley upgraded

from Neutral to Buy. Microchip Technology shares closed at $48.99 on Wednesday. Analysts at Susquehanna upgraded

from Neutral to Positive. KeyCorp shares closed at $12.81 on Wednesday. Piper Jaffray upgraded

from Neutral to Overweight. The price target for ISIS Pharmaceuticals has been raised from $64 to $80. ISIS Pharmaceuticals shares closed at $53.01 on Wednesday. RBC Capital upgraded

from Sector Perform to Outperform. Shopify shares closed at $31.44 on Wednesday. Analysts at Citigroup upgraded

from Neutral to Buy. InterXion Holding shares closed at $29.75 on Wednesday. Analysts at Wells Fargo upgraded

from Market Perform to Outperform. KKR shares closed at $18.45 on Wednesday.